- Home
- INTS vs DATS Comparison
INTS vs DATS Comparison
Compare INTS & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- DATS
- Stock Information
- Founded
- INTS 2012
- DATS 2014
- Country
- INTS United States
- DATS United States
- Employees
- INTS N/A
- DATS N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- INTS Health Care
- DATS Technology
- Exchange
- INTS Nasdaq
- DATS Nasdaq
- Market Cap
- INTS 8.7M
- DATS 10.4M
- IPO Year
- INTS 2023
- DATS 2021
- Fundamental
- Price
- INTS $0.46
- DATS $2.69
- Analyst Decision
- INTS Strong Buy
- DATS
- Analyst Count
- INTS 3
- DATS 0
- Target Price
- INTS $8.50
- DATS N/A
- AVG Volume (30 Days)
- INTS 1.3M
- DATS 168.7K
- Earning Date
- INTS 05-13-2025
- DATS 06-17-2025
- Dividend Yield
- INTS N/A
- DATS N/A
- EPS Growth
- INTS N/A
- DATS N/A
- EPS
- INTS N/A
- DATS N/A
- Revenue
- INTS N/A
- DATS $388.00
- Revenue This Year
- INTS N/A
- DATS N/A
- Revenue Next Year
- INTS N/A
- DATS N/A
- P/E Ratio
- INTS N/A
- DATS N/A
- Revenue Growth
- INTS N/A
- DATS N/A
- 52 Week Low
- INTS $0.29
- DATS $1.01
- 52 Week High
- INTS $5.10
- DATS $9.34
- Technical
- Relative Strength Index (RSI)
- INTS 38.44
- DATS 54.67
- Support Level
- INTS $0.29
- DATS $2.57
- Resistance Level
- INTS $0.63
- DATS $2.86
- Average True Range (ATR)
- INTS 0.09
- DATS 0.18
- MACD
- INTS 0.06
- DATS 0.01
- Stochastic Oscillator
- INTS 50.88
- DATS 69.09
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.